RECRUITING

Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Desmoid tumors (DT) are rare disease of intermediate malignancy with variable and often unpredictable clinical course. There is a growing interest in defining potential risk of recurrence or progression during or after pregnancy and in identifying potential obstetrical risks and infertility rate of desmoid patients. Aim of the study: * to define the impact of pregnancy on diagnosis, progression and recurrence of DT; * to define the risks related to DT of obstetrical risks and decisions to interrupt or avoid pregnancy after the diagnosis of DT.

Official Title

Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History. An International Multicenter Retrospective Observational Study

Quick Facts

Study Start:2022-03-01
Study Completion:2023-05-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05284305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * histologically-proven DT;
  2. * female patients
  3. * fertile age, \>18 years;
  4. * concomitant or subsequent pregnancy (study group), or no history of pregnancy (screening group).
  1. * suspected DT without histological diagnosis • male patients affected by DT
  2. * \<18 years old, and non-fertile age.

Contacts and Locations

Study Contact

Marco Fiore, MD
CONTACT
+390223903234
marco.Fiore@istitutotumori.mi.it

Principal Investigator

Marco Fiore, MD
PRINCIPAL_INVESTIGATOR
Fondazione IRCSS Istituto Nazionale Tumori

Study Locations (Sites)

Brigham and Women Hospital / Dana Farber Cancer Institute
Boston, Massachusetts, 02115
United States

Collaborators and Investigators

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

  • Marco Fiore, MD, PRINCIPAL_INVESTIGATOR, Fondazione IRCSS Istituto Nazionale Tumori

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-01
Study Completion Date2023-05-15

Study Record Updates

Study Start Date2022-03-01
Study Completion Date2023-05-15

Terms related to this study

Keywords Provided by Researchers

  • Desmoid
  • Pregnancy

Additional Relevant MeSH Terms

  • Desmoid
  • Desmoid; Abdominal
  • Pregnancy Loss
  • Pregnancy Complications